US2023321625A1PendingUtilityA1

Semiconductor chip devices and methods for polynucleotide synthesis

Assignee: AVERY DIGITAL DATA INCPriority: Feb 26, 2021Filed: Feb 16, 2023Published: Oct 12, 2023
Est. expiryFeb 26, 2041(~14.6 yrs left)· nominal 20-yr term from priority
B01J 2219/00713B01J 2219/00653B01J 2219/00621B01J 19/0046C40B 40/06B01J 2219/00722B01J 2219/0059B01J 2219/00596B01J 2219/00608C12Q 1/68
67
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Systems and methods for polynucleotide synthesis utilize electrochemical deprotection and novel redox chemistries compatible with advanced CMOS nodes, for highly reliable and massively scalable parallel construction of polynucleotide segments having a desired sequence or sequences. Via use of these exemplary techniques, low-cost and large-scale polynucleotide synthesis is facilitated, for example for data storage and retrieval applications.

Claims

exact text as granted — not AI-modified
1 . (canceled) 
     
     
         2 . A method for modulating pH on a CMOS chip in an addressable, voltage-directed manner, the method comprising:
 applying a first solution to a first set of electrodes of the CMOS chip; and   applying a voltage to the first set of electrodes that modulates the localized pH of the first solution.   
     
     
         3 . The method of  claim 2 , wherein the first solution comprises acetonitrile. 
     
     
         4 . The method of  claim 2 , wherein the first solution comprises two components. 
     
     
         5 . The method of  claim 4 , wherein the two components comprise a first quinone and a second quinone. 
     
     
         6 . The method of  claim 5 , wherein the ratio of the first quinone to the second quinone is greater than 2. 
     
     
         7 . The method of  claim 2 , wherein the first solution comprises three components. 
     
     
         8 . The method of  claim 7 , wherein the first solution comprises a first quinone, a second quinone, and acetonitrile. 
     
     
         9 . The method of  claim 2 , wherein the voltage applied is less than about 1.5V. 
     
     
         10 . The method of  claim 2 , wherein the voltage applied is about 0.9V. 
     
     
         11 . The method of  claim 2 , wherein the voltage is modulated. 
     
     
         12 . The method of  claim 11 , wherein the voltage is modulated in time. 
     
     
         13 . The method of  claim 2 , further comprising synthesizing polynucleotides on the CMOS chip. 
     
     
         14 . The method of  claim 13 , wherein synthesizing polynucleotides comprises a step of:
 removing a protecting group on the CMOS chip.   
     
     
         15 . The method of  claim 14 , wherein synthesizing polynucleotides further comprises steps of:
 providing, on or adjacent to the first set of electrodes, a polynucleotide synthesis region functionalized to support polynucleotide synthesis;   identifying a target nucleotide to be incorporated;   applying a voltage to the first set of electrodes to drive acid generation for deprotection; and   providing a desired monomer in either the first solution or a second solution.   
     
     
         16 . The method of  claim 15 , wherein the polynucleotide synthesis region is planar. 
     
     
         17 . The method of  claim 16 , further comprising:
 providing a second set of electrodes that surround the first set of electrodes in a planar manner.   
     
     
         18 . The method of  claim 15 , wherein the electrodes and synthesis regions are arranged as an array with a pitch selected from the group consisting of less than 30 microns, less than 10 microns, and less than 1 micron. 
     
     
         19 . The method of  claim 15 , wherein a plurality of polynucleotide synthesis steps are performed until a target polynucleotide sequence is generated. 
     
     
         20 . The method of  claim 19 , wherein at least a portion of the target polynucleotide sequence contains error correction sequence elements. 
     
     
         21 . The method of  claim 19 , wherein at least a portion of a target polynucleotide sequence population comprises a consensus error corrected sequence.

Join the waitlist — get patent alerts

Track US2023321625A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.